{
    "2020-07-14": [
        [
            {
                "time": "",
                "original_text": "高瓴突然出手！这两家公司，市值狂涨180亿！",
                "features": {
                    "keywords": [
                        "高瓴",
                        "市值",
                        "狂涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "健康元营收增速放缓 引入战投高瓴资本获两涨停 盈利能力下降",
                "features": {
                    "keywords": [
                        "健康元",
                        "高瓴资本",
                        "营收增速放缓",
                        "涨停",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "24家公司获海外机构调研",
                "features": {
                    "keywords": [
                        "海外机构",
                        "调研"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本A股布局青睐医药股 全额认购健康元定增",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "A股",
                        "医药股",
                        "健康元",
                        "定增"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本全额认购健康元22亿募资 耗资70亿参与五公司定增浮盈44亿",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "健康元",
                        "定增",
                        "浮盈"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}